Nail toxicity is an uncommon cutaneous adverse effect of imatinib mesylate. Here, we have described a 45-year-old female, a diagnosed case of Philadelphia positive chronic myeloid leukemia, who was on imatinib mesylate for the past 3 months and developed bluish discoloration of the nails. This discoloration was related to the drug imatinib mesylate because the patient was only on imatinib and thyroxine medication. No any other skin-related diseases was present, which can lead to her nail changes.
Bluish Nail; Imatinib; Chronic Myeloid Leukemia
Dendritic spine density changes and homeostatic synaptic scaling: a meta-analysis of animal studies.
Moulin TC, RayÃªe D, SchiÃ¶th HB
Neural regeneration research. 2022; 17(1): 20-24
Effects of electroacupuncture on pain sensation in a rat model of hyperalgesia with nicotine dependence.
Wang SJ, Zhang YP, Candiotti KA
Neural regeneration research. 2022; 17(4): 905-910
Stroke recovery enhancing therapies: lessons from recent clinical trials.
Rogalewski A, SchÃ¤bitz WR
Neural regeneration research. 2022; 17(4): 717-720
Exploration of the mechanism by which icariin modulates hippocampal neurogenesis in a rat model of depression.
Zeng NX, Li HZ, Wang HZ, Liu KG, Gong XY, Luo WL, Yan C, Wu LL
Neural regeneration research. 2022; 17(3): 632-642
Time-to-enrollment in clinical trials investigating neurological recovery in chronic spinal cord injury: observations from a systematic review and ClinicalTrials.gov database.
Moinuddin FM, Yolcu YU, Wahood W, Zreik J, Goncalves S, Windebank AJ, Qu W, Bydon M
Neural regeneration research. 2022; 17(5): 953-958